A single-arm phase 2 study of talimogene laherparepvec in patients with lower-risk invasive cutaneous squamous cell cancerDelaney Stratton, Clara Curiel‐Lewandrowski, S Sundararajan et al.|Journal of the American Academy of Dermatology|2025Cited by 0